CORRECTION

Correction: Urotensin II Inhibits DoxorubicinInduced Human Umbilical Vein Endothelial Cell Death by Modulating ATF Expression and via the ERK and Akt Pathway The PLOS ONE Staff

The Data Availability statement for this paper is incorrect. The correct statement is: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files. Please see the Supporting Information below.

Supporting Information S1 Data (RAR)

Reference 1.

Chen Y-L, Tsai Y-T, Lee C-Y, Lee C-H, Chen C-Y, Liu C-M, et al. (2014) Urotensin II Inhibits DoxorubicinInduced Human Umbilical Vein Endothelial Cell Death by Modulating ATF Expression and via the ERK and Akt Pathway. PLoS ONE 9(9): e106812. doi:10.1371/journal.pone.0106812 PMID: 25268131

OPEN ACCESS Citation: The PLOS ONE Staff (2015) Correction: Urotensin II Inhibits Doxorubicin-Induced Human Umbilical Vein Endothelial Cell Death by Modulating ATF Expression and via the ERK and Akt Pathway. PLoS ONE 10(3): e0118879. doi:10.1371/journal. pone.0118879 Published: March 5, 2015 Copyright: © 2015 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PLOS ONE | DOI:10.1371/journal.pone.0118879 March 5, 2015

1/1

Correction: Urotensin II inhibits doxorubicin-induced human umbilical vein endothelial cell death by modulating ATF expression and via the ERK and Akt pathway.

Correction: Urotensin II inhibits doxorubicin-induced human umbilical vein endothelial cell death by modulating ATF expression and via the ERK and Akt pathway. - PDF Download Free
77KB Sizes 1 Downloads 6 Views